SARS Envelope Synthetic Peptide, PEP-0262, from Invitrogen.
SARS Envelope Synthetic Peptide, PEP-0262, from Invitrogen.
A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.
Conservation
Storage: -20°C.
Formulation
Concentration: 200 μg/mL.
Regulatory status
Research only (RUO).
Packaging
Packaging: 50 μg.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15256479 |
| Specifications |
| Species | Virus |
| Purification method | Purified |
| Common name | SARS Envelope Protein |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formula | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| For use with (application) | Blocking Assay, Control |
| Lyophilized | No |
| Product type | Peptide |
| Quantity | 50 μg |
| Regulatory status | RUO - research use only |
| Storage and shipping |
| Content and storage | -20°C |
| Conservative | 0.02% sodium azide |
| Storage stamp | PBS |
Origin and customs
| Manufacturer ref. | PEP-0262 |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3824 99 96 00 |
|---|
A question or a specific configuration?
Contact us for a quote.